Infliximab- and methotrexate-resistant rebound of psoriasis after discontinuation of efalizumab (Raptiva®)

被引：5

作者：

Thielen, A. M. ^{[1
]}

Barde, C. ^{[1
]}

Saurat, J. H. ^{[1
]}

机构：

[1] Univ Hosp Geneva, Dept Dermatol, CH-1211 Geneva, Switzerland

来源：

关键词：

D O I：

10.1111/j.1365-2133.2006.07447.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：846 / 847

页数：3

共 4 条

[1] Eczematous drug eruption after infliximab [J].

Dumont-Berset, M ;

Laffitte, E ;

Gerber, C ;

Dudler, J ;

Panizzon, RG .

[2]

Leonardi Craig L, 2004, Dermatol Ther, V17, P393, DOI 10.1111/j.1396-0296.2004.04042.x

Thielen, AM ;

Kuenzli, S ;

Saurat, JH .

[4] Atopic dermatitis-like eruption precipitated by infliximab [J].

Wright, RC .